Purchase Order 75N91024P00723
Award Date
9/23/24
Potential Completion Date
10/22/24
Potential Value
$12K
Federal Agency
National Cancer Institute
Awardee
Arima Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Costa, CA 92011, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order contract was awarded by the National Institute of Environmental Health Sciences, a civilian federal agency, to Arima Genomics, Inc., a for-profit company based in Carlsbad, California. The $47,100 contract is for the provision of ARIMAGENOMICS, HIC AND HICHIP services, which likely relates to advanced genomic research and analysis capabilities provided by the vendor, such as proximity ligation library construction, genome-wide sequencing, and assays for...
This is a federal contract award to Arima Genomics, Inc., a for-profit company based in Carlsbad, California. The $14,400.10 firm fixed-price purchase order contract was awarded by the National Institute of Environmental Health Sciences, a civilian agency, on August 20, 2020. The contract has a completion date of August 31, 2021 and does not have a set-aside designation. Arima Genomics specializes in advanced genomic research services and laboratory supplies, with a focus on Hi-C technology,...
This federal contract award, valued at $13,080.00, was made by the Civilian Northeast Area agency to the prime contractor Arima Genomics, Inc. The contract is for the delivery of "HI-C PROXIMITY-GENOME ASSEMBLY" services and does not have a set-aside designation. Arima Genomics, Inc. is a for-profit organization that provides specialized genomic research services and laboratory supplies, including low-input genome-wide Hi-C mouse gene sequencing, proximity ligation library construction...
The Department of Health and Human Services' National Institutes of Health awarded a $35,103.50 firm fixed-price purchase order to Arima Genomics, Inc. for services to be performed in Bethesda, Maryland between August 7, 2023 and September 29, 2023. The award was made through the Office of Logistics and Acquisition Operations and no set aside designation or associated contract vehicle was indicated. Arima Genomics, Inc. will serve as the prime contractor on this contract to provide unspecified...
This is a firm fixed price purchase order contract awarded by the National Eye Institute, a civilian agency of the U.S. government, to Arima Genomics, Inc., a for-profit organization. The contract, valued at $29,832.28, is for the provision of reagents related to ARIMA GENOMICS INC:1284747 [24-004616]. The contract does not have a set-aside designation. Arima Genomics, Inc. is the prime contractor, and there are no major subcontractors identified. The National Eye Institute is part of the...
This is a $142,990 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract has no set-aside designation. Illumina has previously received prime federal contract awards from other agencies like the CDC, USDA, and VA to provide sequencing systems, reagents, and related services in support of genomics...
This firm fixed-price purchase order contract was awarded by the National Human Genome Research Institute, a component of the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $16,691.74 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously been awarded prime federal...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomics sequencing and analysis solutions. The contract, valued at $15,388.08, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics. Illumina has a history of providing similar products and services to various federal agencies, including the NIH, CDC, USDA, and VA, under...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $3 million firm fixed price purchase order to 10X Genomics, Inc. for genomics products and services. As the prime contractor, 10X Genomics will deliver its genome sequencing platforms and assays to support the agency's cancer research efforts from its Pleasanton, California location through the end of 2023. No subcontractors or set aside designations were indicated. This award draws on...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to 10X Genomics, Inc., a life sciences technology company specializing in products and services for single-cell and spatial analysis applications. The $138,724.20 contract provides a range of genomic analysis platforms, reagents, instruments, and bioinformatics software to support biomedical research, with a...